Covid-19 Impact on Oncology Drug Market, Global Research Reports 2020-2021

2 Global Oncology Drug Quarterly Market Size Analysis

• 2.1 Oncology Drug Business Impact Assessment - COVID-19
  • 2.1.1 Global Oncology Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Oncology Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Oncology Drug Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Oncology Drug Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Oncology Drug Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Oncology Drug Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Oncology Drug Market
• 3.5 Key Manufacturers Oncology Drug Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Oncology Drug Segments, By Type

• 4.1 Introduction
  • 1.4.1 Chemotherapy
  • 1.4.2 Targeted Therapy
  • 1.4.3 Immunotherapy
  • 1.4.4 Hormonal Therapy
  • 1.4.5 Others
• 4.2 By Type, Global Oncology Drug Market Size, 2019-2021
  • 4.2.1 By Type, Global Oncology Drug Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Oncology Drug Price, 2020-2021

5 Impact of Covid-19 on Oncology Drug Segments, By Application

• 5.1 Overview
  • 5.5.1 Blood Cancer
  • 5.5.2 Breast Cancer
  • 5.5.3 gastrointestinal Tract Cancer
  • 5.5.4 Prostate Cancer
  • 5.5.5 Lung Cancer
  • 5.5.6 Skin Cancer
• 5.2 By Application, Global Oncology Drug Market Size, 2019-2021
  • 5.2.1 By Application, Global Oncology Drug Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Oncology Drug Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Roche Ltd
  • 7.1.1 Roche Ltd Business Overview
  • 7.1.2 Roche Ltd Oncology Drug Quarterly Production and Revenue, 2020
  • 7.1.3 Roche Ltd Oncology Drug Product Introduction
  • 7.1.4 Roche Ltd Response to COVID-19 and Related Developments
• 7.2 Novartis AG
  • 7.2.1 Novartis AG Business Overview
  • 7.2.2 Novartis AG Oncology Drug Quarterly Production and Revenue, 2020
  • 7.2.3 Novartis AG Oncology Drug Product Introduction
  • 7.2.4 Novartis AG Response to COVID-19 and Related Developments
• 7.3 Bristol-Myers Squibb
  • 7.3.1 Bristol-Myers Squibb Business Overview
  • 7.3.2 Bristol-Myers Squibb Oncology Drug Quarterly Production and Revenue, 2020
  • 7.3.3 Bristol-Myers Squibb Oncology Drug Product Introduction
  • 7.3.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
• 7.4 Celgene Corporation
  • 7.4.1 Celgene Corporation Business Overview
  • 7.4.2 Celgene Corporation Oncology Drug Quarterly Production and Revenue, 2020
  • 7.4.3 Celgene Corporation Oncology Drug Product Introduction
  • 7.4.4 Celgene Corporation Response to COVID-19 and Related Developments
• 7.5 Johnson & Johnson
  • 7.5.1 Johnson & Johnson Business Overview
  • 7.5.2 Johnson & Johnson Oncology Drug Quarterly Production and Revenue, 2020
  • 7.5.3 Johnson & Johnson Oncology Drug Product Introduction
  • 7.5.4 Johnson & Johnson Response to COVID-19 and Related Developments
• 7.6 Pfizer Inc.
  • 7.6.1 Pfizer Inc. Business Overview
  • 7.6.2 Pfizer Inc. Oncology Drug Quarterly Production and Revenue, 2020
  • 7.6.3 Pfizer Inc. Oncology Drug Product Introduction
  • 7.6.4 Pfizer Inc. Response to COVID-19 and Related Developments
• 7.7 Astra Zenca Plc
  • 7.7.1 Astra Zenca Plc Business Overview
  • 7.7.2 Astra Zenca Plc Oncology Drug Quarterly Production and Revenue, 2020
  • 7.7.3 Astra Zenca Plc Oncology Drug Product Introduction
  • 7.7.4 Astra Zenca Plc Response to COVID-19 and Related Developments
• 7.8 Eli Lilly And Company.
  • 7.8.1 Eli Lilly And Company. Business Overview
  • 7.8.2 Eli Lilly And Company. Oncology Drug Quarterly Production and Revenue, 2020
  • 7.8.3 Eli Lilly And Company. Oncology Drug Product Introduction
  • 7.8.4 Eli Lilly And Company. Response to COVID-19 and Related Developments
• 7.9 Glaxosmithkline Plc
  • 7.9.1 Glaxosmithkline Plc Business Overview
  • 7.9.2 Glaxosmithkline Plc Oncology Drug Quarterly Production and Revenue, 2020
  • 7.9.3 Glaxosmithkline Plc Oncology Drug Product Introduction
  • 7.9.4 Glaxosmithkline Plc Response to COVID-19 and Related Developments
• 7.10 Merck & Co.
  • 7.10.1 Merck & Co. Business Overview
  • 7.10.2 Merck & Co. Oncology Drug Quarterly Production and Revenue, 2020
  • 7.10.3 Merck & Co. Oncology Drug Product Introduction
  • 7.10.4 Merck & Co. Response to COVID-19 and Related Developments
• 7.11 Sanofi
  • 7.11.1 Sanofi Business Overview
  • 7.11.2 Sanofi Oncology Drug Quarterly Production and Revenue, 2020
  • 7.11.3 Sanofi Oncology Drug Product Introduction
  • 7.11.4 Sanofi Response to COVID-19 and Related Developments
• 7.12 Amgen Inc.
  • 7.12.1 Amgen Inc. Business Overview
  • 7.12.2 Amgen Inc. Oncology Drug Quarterly Production and Revenue, 2020
  • 7.12.3 Amgen Inc. Oncology Drug Product Introduction
  • 7.12.4 Amgen Inc. Response to COVID-19 and Related Developments
• 7.13 Abbvie
  • 7.13.1 Abbvie Business Overview
  • 7.13.2 Abbvie Oncology Drug Quarterly Production and Revenue, 2020
  • 7.13.3 Abbvie Oncology Drug Product Introduction
  • 7.13.4 Abbvie Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Oncology Drug Supply Chain Analysis
  • 8.1.1 Oncology Drug Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Oncology Drug Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Oncology Drug Distribution Channels
  • 8.2.2 Covid-19 Impact on Oncology Drug Distribution Channels
  • 8.2.3 Oncology Drug Distributors
• 8.3 Oncology Drug Customers

9 Key Findings

10 Appendix

• 10.1 About Us